Amplifying hepatic L-aspartate levels suppresses CCl4-induced liver fibrosis by reversing glucocorticoid receptor β-mediated mitochondrial malfunction

• প্রধান লেখক: Rui Su (লেখক), Hui-Ling Fu (লেখক), Qian-Xue Zhang (লেখক), Chen-Yan Wu (লেখক), Guan-Yu Yang (লেখক), Jun-Jie Wu (লেখক), Wen-Jie Cao (লেখক), Jin Liu (লেখক), Zhong-Ping Jiang (লেখক), Cong-Jun Xu (লেখক), Yong Rao (লেখক), Ling Huang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2024-08-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Liver fibrosis is a determinant-stage process of many chronic liver diseases and affected over 7.9 billion populations worldwide with increasing demands of ideal therapeutic agents. Discovery of active molecules with anti-hepatic fibrosis efficacies presents the most attacking filed. Here, we reveal...